SCHEMBL23043597

SCHEMBL23043597

Nc1ccccc1N1CCC2(CC1)CC2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.62
ADRA2C P18825 1/20 0.58
USP2 O75604 6/20 0.55
GAA P10253 4/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
DRD2 P14416 2/20 0.45
KDM4E B2RXH2 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP11B1 P15538 3/20 0.41
CYP11B2 P19099 3/20 0.41
HTR1A P08908 1/20 0.41
ADRA1B P35368 1/20 0.41
DRD3 P35462 1/20 0.40
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
CYP2C9 P11712 3/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 1/20 0.37
CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043708 0.92 KEAP1 (0.63) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL11775877 0.83 ADRA2C (0.79) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL23152040 0.83 ADRA2C (0.79) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL23043615 0.82 ADRA2C (0.61) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL5092004 0.82 KEAP1 (0.60) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL14206537 0.79 CYP2D6 (0.57) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL484010 0.79 KEAP1 (0.95) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL30664040 0.79 KEAP1 (0.87) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL29938274 0.79 KEAP1 (0.95) KEAP1ADRA2CUSP2GAAMEN1
SCHEMBL23536222 0.78 LGMN (0.58) KEAP1ADRA2CUSP2GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed
WO-2021041866-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 KEAP1 3912/4885ADRA2C 2427/4885USP2 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.